Literature DB >> 9515771

Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and pre-existing specific antibodies.

D Hober1, T L Nguyen, L Shen, D Q Ha, V T Huong, S Benyoucef, T H Nguyen, T M Bui, H K Loan, B L Le, A Bouzidi, D De Groote, M T Drouet, V Deubel, P Wattré.   

Abstract

The pathogenesis of dengue hemorrhagic fever (DHF) is not well known, but the role of host factors has been suggested. The level of immunoreactive circulating and cell-generated tumor necrosis factor alpha (TNF alpha) was studied in 35 patients with DHF; its relationship with virus isolation and/or genome detection by reverse transcription polymerase chain reaction (RT-PCR) and specific antibodies were detected by hemagglutination inhibition (HI). Large variation of TNF alpha plasma levels was obtained in dengue-infected patients at the same stage of the disease and at the same day after infection. Most of the patients (14 out of 17 patients) who displayed augmented spontaneous in vitro production of TNF alpha by heparinized whole-blood culture compared with controls also had elevated levels of TNF alpha in the plasma. The TNF alpha values in lipopolysaccharide and phytohemagglutinin heparinized whole-blood cultures were not higher in patients than in controls, but low TNF alpha levels were obtained in three out of 30 patients. An inverse correlation was observed between spontaneous in vitro TNF alpha production and viral replication, which raises the issue of the antiviral effect of TNF alpha in dengue infection. The results do not support the hypothesis of the role of antibody-dependent enhancement giving rise to increased viremic titers and production of TNF alpha in patients. The present study demonstrates the activation of the TNF alpha-producing cells in dengue-infected patients and suggests further investigation to define the mechanism and the role of TNF alpha in the pathogenesis of dengue virus infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515771     DOI: 10.1002/(sici)1096-9071(199803)54:3<210::aid-jmv12>3.0.co;2-l

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line.

Authors:  C A King; J S Marshall; H Alshurafa; R Anderson
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.

Authors:  Beatriz Sierra; Ana B Pérez; Mayling Alvarez; Gissel García; Katrin Vogt; Eglys Aguirre; Kathrin Schmolke; Hans-Dieter Volk; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2012-07-16       Impact factor: 2.345

3.  Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved.

Authors:  J T Jan; B H Chen; S H Ma; C I Liu; H P Tsai; H C Wu; S Y Jiang; K D Yang; M F Shaio
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais.

Authors:  Sasijit Vejbaesya; Panpimon Luangtrakool; Komon Luangtrakool; Siripen Kalayanarooj; David W Vaughn; Timothy P Endy; Mammen P Mammen; Sharone Green; Daniel H Libraty; Francis A Ennis; Alan L Rothman; Henry A F Stephens
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

5.  Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice.

Authors:  I-Chun Chen; Shih-Min Wang; Chun-Keung Yu; Ching-Chuan Liu
Journal:  Med Microbiol Immunol       Date:  2013-02-14       Impact factor: 3.402

6.  Dengue: A Clinicohaematological Profile.

Authors:  M Banerjee; T Chatterjee; G S Choudhary; V Srinivas; V K Kataria
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Transcriptional activation of interferon-stimulated genes but not of cytokine genes after primary infection of rhesus macaques with dengue virus type 1.

Authors:  Carlos A Sariol; Jorge L Muñoz-Jordán; Kristina Abel; Lymarie C Rosado; Petraleigh Pantoja; Luis Giavedoni; Idia Vanessa Rodriguez; Laura J White; Melween Martínez; Teresa Arana; Edmundo N Kraiselburd
Journal:  Clin Vaccine Immunol       Date:  2007-04-11

8.  Cells in dengue virus infection in vivo.

Authors:  Sansanee Noisakran; Nattawat Onlamoon; Pucharee Songprakhon; Hui-Mien Hsiao; Kulkanya Chokephaibulkit; Guey Chuen Perng
Journal:  Adv Virol       Date:  2010-08-12

Review 9.  Role of microparticles in dengue virus infection and its impact on medical intervention strategies.

Authors:  Kristina Bargeron Clark; Hui-Mien Hsiao; Sansanee Noisakran; Jih-Jin Tsai; Guey Chuen Perng
Journal:  Yale J Biol Med       Date:  2012-03-29

10.  Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells.

Authors:  Siew Pei Ong; Ling Min Lee; Yew Fai Ivan Leong; Mah Lee Ng; Justin Jang Hann Chu
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.